ICD-10 Code D47.02 | Systemic mastocytosis Symptoms, Diagnosis, Billing

Systemic mastocytosis is a rare hematological disorder characterized by the abnormal proliferation of mast cells in various tissues, leading to a range of symptoms including skin lesions, gastrointestinal disturbances, and anaphylaxis. Accurate coding with ICD-10 Code D47.02 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources are allocated effectively.

What is ICD-10 Code D47.02 for Systemic mastocytosis?

ICD-10 Code D47.02 represents systemic mastocytosis, a condition where mast cells accumulate in the bone marrow and other organs, causing symptoms such as flushing, abdominal pain, and anaphylactic reactions. This code should be used in clinical documentation and billing when diagnosing patients with systemic mastocytosis to ensure accurate representation of the patient's condition and facilitate appropriate treatment.

ICD-10 Code D47.02 – Clinical Definition and Explanation of Systemic mastocytosis

Systemic mastocytosis is caused by mutations in the KIT gene, leading to uncontrolled mast cell growth. The condition can progress and result in significant morbidity, necessitating medical intervention. Early diagnosis and treatment are crucial to manage symptoms and prevent complications.

Key Clinical Features:

• Presence of skin lesions such as urticaria pigmentosa.
• Gastrointestinal symptoms including nausea, vomiting, and diarrhea.
• Anaphylactic reactions triggered by various stimuli.
• Bone pain or fractures due to mast cell infiltration in the bone.

ICD-10 Code D47.02 for Systemic mastocytosis – SOAP Notes & Clinical Use

ICD-10 Code D47.02 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It plays a critical role in both acute and chronic care settings, ensuring comprehensive documentation that supports clinical decision-making and billing processes.

What Does ICD-10 Code D47.02 for Systemic mastocytosis Mean in SOAP Notes?

In SOAP notes, ICD-10 Code D47.02 connects subjective patient-reported symptoms with objective clinical findings, facilitating a formal diagnosis. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code D47.02 – Systemic mastocytosis

Systemic mastocytosis may require hospitalization for severe cases, particularly those with anaphylaxis or significant organ involvement. Treatment focuses on symptom management and disease control.

Antibiotic Therapy:

• Not applicable as systemic mastocytosis is not an infectious condition.

Supportive Care:

• Antihistamines to manage allergic symptoms.
• Corticosteroids for severe inflammation.
• Avoidance of known triggers to prevent anaphylactic reactions.

Infection Control:

• Standard precautions should be taken to prevent infections in immunocompromised patients.

How to Document Symptoms of Systemic mastocytosis (ICD-10 D47.02) in SOAP Notes

Subjective:

• Patient reports recurrent episodes of flushing and itching.
• History of gastrointestinal distress after eating certain foods.
• Previous anaphylactic reaction requiring emergency treatment.
• Family history of mastocytosis or related allergic conditions.

Objective:

• Skin examination reveals urticaria pigmentosa lesions.
• Vital signs: BP 110/70 mmHg, HR 88 bpm, RR 16 breaths/min.
• Laboratory tests show elevated tryptase levels.
• Bone marrow biopsy indicates increased mast cell proliferation.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Systemic mastocytosis (ICD-10 Code D47.02)

Assessment:

• Diagnosis: Systemic mastocytosis, moderate severity.
• ICD-10 Code: D47.02.
• Common triggers include certain foods, medications, and environmental factors.
• Patient exhibits significant symptoms impacting quality of life.

Plan:

• Initiate treatment with antihistamines and corticosteroids.
• Educate patient on trigger avoidance and anaphylaxis action plan.
• Schedule follow-up appointments for symptom monitoring.
• Consider referral to an allergist or hematologist for specialized care.

Treatment & Plan Section for ICD-10 Code D47.02 – Systemic mastocytosis

• First-line pharmacologic treatments include antihistamines and corticosteroids.
• Non-pharmacologic strategies involve lifestyle modifications and allergen control.
• Monitoring practices include regular follow-up visits and symptom tracking.
• Patient education on recognizing anaphylaxis and emergency response.

Using ICD-10 Code D47.02 for Systemic mastocytosis in Billing & SOAP Note Compliance

• Select accurate subcodes based on clinical severity or complications.
• Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
• Ensure treatment plans align with clinical guidelines to support justified billing.
• Only list CPT codes that are commonly billed with ICD-10 Code D47.02 based on standard medical coding practices.

Related ICD-10 Codes Often Used with Systemic mastocytosis

• D47.01 – Cutaneous mastocytosis
• D47.09 – Other mastocytosis
• C84.60 – Other specified peripheral T-cell lymphoma
• D47.0 – Mastocytosis, unspecified

ICD-10 Code D47.02 in Medical Billing and Insurance for Systemic mastocytosis

ICD-10 Code D47.02 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.

Billing Notes:

• Ensure accurate documentation of symptoms and treatment plans to support claims.
• Use this code in conjunction with relevant CPT codes for comprehensive billing.
• Document all relevant patient history and clinical findings to justify the diagnosis.
• Be aware of payer-specific guidelines for coding and billing related to systemic mastocytosis.

Common CPT Pairings: